KRM Ayurveda Plans 80-Bed South Delhi Hospital for ₹2.25 Cr
Key highlights
- KRM Ayurveda plans an 80-bed Ayurveda hospital at D-57, East of Kailash, South Delhi.
- The proposed hospital requires estimated investment of ₹2.25 crore to ₹2.40 crore.
- The facility will span approximately 4,050 square feet and operate under the Karma Ayurveda brand.
- KRM Ayurveda has stated a target of reaching 500 total beds by the end of FY27.
powered by IRIS

KRM Ayurveda Limited has proposed an 80-bed Ayurveda hospital in East of Kailash, South Delhi, with estimated investment starting at ₹2.25 crore and extending to ₹2.40 crore. The project, to operate under the Karma Ayurveda brand, is to be funded partly through IPO proceeds and internal accruals, subject to statutory approvals.
Know KRM Ayurveda inside out
Results, valuation, peers and who's buying, in one view.
What has KRM Ayurveda announced for South Delhi?
KRM Ayurveda has announced plans to establish an 80-bed Ayurveda hospital at D-57, East of Kailash in South Delhi. The proposed facility will operate under the Karma Ayurveda brand and is intended to expand the company's healthcare infrastructure and service offering in the region.
The hospital is planned across approximately 4,050 square feet. KRM Ayurveda's hospitals and clinics provide in-patient and out-patient care, Panchakarma therapies, specialised clinics, wellness packages, medicinal sales, and diet and lifestyle counselling. The filing does not specify a construction completion date or an operational start date.
The announcement was made to the stock exchanges on 19 November 2026. The company said services are expected to begin shortly after it receives the required statutory approvals and completes operational arrangements. This makes approvals and execution the immediate milestones for the project.
How much will the East of Kailash hospital cost?
The estimated investment for the proposed hospital is ₹2.25 crore to ₹2.40 crore. KRM Ayurveda has identified IPO proceeds as the primary funding source, with internal accruals to be used as applicable.
The disclosed estimate indicates a defined capital outlay for adding 80 beds in South Delhi. However, the company has not disclosed a detailed break-up between fit-outs, medical equipment, staffing, lease-related costs, or other operational expenditure. It has also not provided expected revenue, profitability, occupancy, or payback metrics for the facility.
The company has stated that the facility will serve a new catchment area in an established South Delhi residential and commercial locality. The announcement does not disclose the current bed base, existing South Delhi capacity, or the number of employees proposed for the new hospital.
Got a follow-up? Ask IRIS
Why is KRM Ayurveda adding an 80-bed hospital?
KRM Ayurveda is adding the proposed hospital as part of its stated plan to scale its healthcare footprint. The East of Kailash site would add a new physical location under the Karma Ayurveda brand and broaden the company's capacity to provide its Ayurveda-led healthcare services in South Delhi.
The company has also disclosed a target to reach 500 total beds by the end of FY27. The proposed 80-bed addition is therefore relevant to the stated network expansion plan. The filing does not state how many of the planned 500 beds have already been commissioned, so progress towards that target cannot be quantified from the available disclosure.
KRM Ayurveda has further referred to a plan to add 30 new super-specialty clinics in FY27. The hospital proposal and clinic expansion target point to a strategy focused on expanding the service network, although the company has not provided a combined capital expenditure budget or rollout schedule for these initiatives.
What does the project mean for investors and operations?
For investors, the immediate significance is that KRM Ayurveda intends to deploy part of its IPO proceeds towards an identified capacity-expansion project. The planned hospital would increase the company's operating infrastructure by 80 beds once approvals are obtained and the facility begins services.
The announcement does not include a share-price reaction, financial guidance, expected utilisation levels, or a timeline for ramp-up. As a result, the eventual contribution to revenue and earnings cannot be determined from the filing. Investors will need to assess later disclosures on commissioning, operating costs, patient volumes, and the hospital's financial performance.
For customers in the East of Kailash catchment, the proposed facility is intended to add access to Karma Ayurveda's services, including consultation, treatment, therapies, wellness programmes, and medicine dispensing. Actual availability will depend on the completion of regulatory and operational requirements.
What are the next milestones for KRM Ayurveda's hospital plan?
The next disclosed milestones are the receipt of statutory approvals, completion of operational arrangements, and commencement of services at the South Delhi hospital. KRM Ayurveda has not announced a fixed date for any of these steps.
The company's subsequent quarterly results may offer further detail on the use of IPO proceeds, expansion expenditure, and the status of its wider FY27 capacity goals. Updates on the proposed 30 super-specialty clinics and the 500-bed network target will also be relevant to tracking the pace of expansion.
Conclusion
KRM Ayurveda's proposed 80-bed hospital at East of Kailash represents a planned expansion of its healthcare network in South Delhi. The project carries an estimated investment of ₹2.25 crore to ₹2.40 crore, funded primarily through IPO proceeds and supplemented by internal accruals where required.
The key items to watch are statutory approvals, the start of operations, and disclosures on execution costs and utilisation. Investors can also monitor the company's progress towards its stated target of 500 total beds and 30 new super-specialty clinics by the end of FY27.


